Investors & Media

Transformative science, targeted medicines

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

SEC Filings

SEC Filings

Filing date	Form	Description	View
Nov 24, 2017	4/A	Amendment to a previously filed 4	View HTML 0001179110-17-014597.pdf 0001179110-17-014597.rtf 0001179110-17-014597.xls
Mar 17, 2021	4/A	Amendment to a previously filed 4	View HTML 0001179110-21-003568.pdf 0001179110-21-003568.rtf 0001179110-21-003568.xls
Mar 31, 2022	4/A	Amendment to a previously filed 4	View HTML 0001415889-22-003506.pdf 0001415889-22-003506.rtf 0001415889-22-003506.xls
May 01, 2015	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001104659-15-033273.pdf 0001104659-15-033273.rtf 0001104659-15-033273.xls
Mar 28, 2016	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001179110-16-022254.pdf 0001179110-16-022254.rtf 0001179110-16-022254.xls
Mar 31, 2022	3/A	An amendment to a 3 filing. Non-EDGAR filing	View HTML 0001415889-22-003505.pdf 0001415889-22-003505.rtf 0001415889-22-003505.xls
Jun 25, 2015	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-15-002739.pdf 0000315066-15-002739.rtf
Dec 10, 2015	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-15-003362.pdf 0000315066-15-003362.rtf
Feb 12, 2016	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000315066-16-004895.pdf 0000315066-16-004895.rtf
Feb 16, 2016	SC 13G/A	An amendment to the SC 13G filing	View HTML 0000921895-16-003392.pdf 0000921895-16-003392.rtf 0000921895-16-003392.xls

Continue